Moderna Stock Plunges 25%—Wiping Out $18 Billion After Historic Cancer Vaccine Breakthrough

Moderna Stock Plunges 25%—Wiping Out $18 Billion After Historic Cancer Vaccine Breakthrough

💼 Finance & Business
📡 2 sourcesFast Company, Forbes Business
Summary

The biotech giant posted positive trial results of a cancer vaccine, boosting shares at a record-setting pace before investors pulled back.

Visit the original source for the full article

🌐 Translate to:
More from 💼 Finance & Business →